Home apnea monitoring is one of the preventive strategies available for infants at risk for sudden infant death. Although monitoring infants at risk is not universally accepted, 1 some experts advocate it, and its application is widespread. Parents have been known to discontinue home apnea monitoring against medical advice and, in some tragic cases, have left their infants unmonitored at the time of their sudden death. 2 Indeed, lack of quantitative data documenting the extent of home monitor use has been a major limiting factor in the ability to assess the effectiveness of monitoring. 3, 4 Studies of compliance with antibiotic regimens show that it can be poor even with a high risk of significant sequelae. 5 In a meta analysis, overall compliance with home medical treatment was estimated to be as low as 30%. 6 Several reports suggest that noncompliance may play a role in the death of infants while on apnea monitors. Davidson-Ward et al. 4 showed that of 1841 infants monitored at risk for sudden infant death syndrome, 5 of the 7 deaths were associated with noncompliance or technical errors in monitoring at the time of death. Meny et al. 3 also showed that at least six of the ten deaths of infants who died while on home monitoring prescription were noncompliant at the time of Original Article
death. Kelly 7 reported that 12 of the 21 deaths in 1445 monitored infants were associated with noncompliance.
Until recently, compliance with home apnea monitoring was assessed by subjective methods such as parental recall. The accuracy of this information is limited by the willingness of parents to acknowledge noncompliance. 8 The availability of monitors with electronic memory offers a more objective evaluation of compliance. To date, there are no reports of interventions that have led to improved compliance. Alternatively, it is possible that parents may be more compliant with a medical regimen when there is more frequent medical contact. This study was designed to test whether weekly telephone contact with a health professional would improve the use of the home apnea monitor.
MATERIALS AND METHODS
This prospective, single-blind, randomized clinical trial was done at MetroHealth Medical Center from April 1996 to December 1997. Consecutive patients discharged from the neonatal intensive care nursery, newborn nursery, and pediatric floor were screened for eligibility. A total of 65 subjects were enrolled in the study at or within a week of discharge from the hospital. All infants discharged on an apnea monitor were eligible for the study. This included preterm infants with abnormal pneumocardiogram (PCG) recordings, patients with bronchopulmonary dysplasia requiring oxygen support, siblings of a sudden infant death syndrome victim, and others with various pulmonary, cardiac, or neurologic problems. Infants without a home telephone or participating in any other home monitoring study were excluded. Subjects were randomized to either the standard or the telephone group using a stratified balanced block technique to minimize pretreatment differences. The randomization strata included the following group assignments: preterm infant or other diagnosis, medications for apnea, and insurance as a marker for socioeconomic status (SES). Patients on Medicaid were considered as having a lower SES, whereas those with private insurance were identified as a having higher SES. Prenatal substance abuse was ascertained by maternal self-reporting and/or by a universal urine toxicology screening report of high-risk groups.
Care for all of the infants on home apnea monitors included: access to a physician in the neonatal intensive care unit at all times, initial instruction as well as support 24 hours per day from the monitor vending company, and follow-up visits with a neonatologist or pediatrician within 2 weeks of discharge and about every month for the first 3 months thereafter in the neonatal specialty clinic and/or well child care clinic. Most infants had one to three visits by a home nurse in the first 2 weeks following discharge. The caregivers of all infants discharged from the hospital on apnea monitors received instructions to use the monitor at all times during the day and night during the first 4-week period, except when bathing the infant. They were asked to use the monitor at all unattended and night times during the second 4-week period. At the time of enrollment in the study, all parents were told that compliance was being monitored. The standard group received the care as described above, while the telephone group had the above care plus an additional phone call consisting of a structured interview every week for a total of 8 weeks. Table 1 lists the questions that were asked by the research associate during the telephone interview. The questionnaire addressed the use of monitors and the well-being of the baby, including any need for an office visit or hospitalization. Questions about the monitor included the occurrence of alarms for apnea and bradycardia and the need for cardiopulmonary resuscitation or stimulation.
The study population consisted of infants discharged on home apnea monitors (Aequitron 9500, Aequitron 9550; Aequitron Medical, Minneapolis, MN and Healthdyne, Marietta, GA). These monitors were equipped with electronic memory to record compliance and events. Families of infants sent home on an apnea monitor received cardiopulmonary resuscitation and monitor instruction by specially trained personnel from the monitor company (Seeley Medical Company, Cleveland, OH). The monitors were downloaded on instruction from the physician based on clinical symptoms, when parents expressed concerns, or when the event recorder reached its memory capacity. All downloads were transferred to an individual patient disk.
The compliance data were interpreted by one person (C. G. M.) who was blinded to the patient group assignment. Monitor use was determined by calendar days (midnight to midnight) in hours and minutes. All PCGs were read independently by a pediatric pulmonologist. An abnormal PCG was defined as the presence of one or more of the following criteria: (1) Periodic breathing of Ͼ6%; (2) prolonged apnea, defined as central, obstructive, or mixed apnea lasting for Ն20 seconds; (3) pathologic apnea, defined as central, obstructive, or mixed apnea lasting for Ͻ20 seconds accompanied by bradycardia and/or oxygen desaturation; (4) bradycardia, defined as a two-third drop in the baseline heart rate; and (5) oxygen desaturation below 80% for Ͼ4 seconds.
Outcome Measures
The primary outcome measure was compliance during the 8-week time period; compliance was considered to be the percentage of time as well as the number of hours per day that the infant spent on the monitor. Families were considered 100% compliant if they used the monitor for the 24 hours per day for the entire study period. Secondary outcome measures were compliance during the first 4 weeks and the second 4 weeks of the study. Other factors that could potentially influence compliance were also analyzed, including PCG results at the time of discharge, maternal age, education, SES, and employment.
Approval
This study was approved by the Institutional Review Board at MetroHealth Medical Center. Written parental consent was obtained from all the participants.
Data Analysis
Interval data are reported as the mean and SD. Differences between the two groups were determined by the following bivariate statistics: parametric interval data by the pooled or separate variance Student's t-test dependent on the "F" ratio of the variances, ordinal or nonparametric interval data by the Mann-Whitney U-test, and categorical data by -squared analysis. Statistical significance was set a priori as Ͻ0.05 (two-tailed). The data were analyzed using Statistical Package for Social Sciences (SPSS) PC for Windows Version 6.1 (SPSS, Chicago, IL). With the total sample size of 62 patients, our study has a power of 80% (type 2 error of 0.20) with a type 1 error of 0.05 (twotailed) for detecting a difference of 18% (85.7% versus 67.7%) in compliance between the telephone and standard group, respectively.
RESULTS

Patient Characteristics
During the 18-month study period, all infants at our institution were consecutively screened for possible enrollment in the study. Of the 69 patients eligible, 65 agreed to participate in the study (4 refused informed consent). Of the 65 patients, only one (randomized to the standard group) was lost to follow-up. The other two patients excluded from the analysis were compliant with all aspects of the study but we were technically unable to download the compliance data from the monitor. The attrition rate secondary to lost for follow-up was 1.6%. Maternal and infant characteristics subdivided by demographic factors are shown in Table 2 . The telephone group (n ϭ 30) and the standard group (n ϭ 32) were similar ( p Ͼ 0.10) with respect to birth weight, gestational age, maternal age, and commercial insurance, a marker of higher SES. Maternal education, marital status, maternal employment, and substance abuse were also similar in both groups.
Compliance
Compliance with the apnea monitor was similar between the patients receiving weekly telephone contact versus the standard group for all time periods (Table 3 ). The infants in the telephone group had a compliance of 69.3 Ϯ 24.7% (16.7 Ϯ 6.0 hours/day) compared with 67.7 Ϯ 26.2% (16.1 Ϯ 6.5 hours/day) in the standard group. In the first 4 weeks, compliance was 74.7 Ϯ 24.9% (17.9 Ϯ 5.9 hours/day) in the telephone group and 75 Ϯ 27.8% (18.2 Ϯ 6.6 hours/day) in the standard group. In the second 4-week period, compliance was 63.4 Ϯ 29.1% (15.2 Ϯ 7.0 hours/day) in the telephone group and 58.9 Ϯ 30.9% (14.1 Ϯ 7.4 hours/day) in the standard group.
An abnormal PCG result at the time of hospital discharge was associated with higher compliance. Compliance for the entire 8-week study period (73.1 Ϯ 22.0 versus 52.1 Ϯ 28.5%, p ϭ 0.02) (17.5 Ϯ 5.2 versus 12.5 Ϯ 6.8 hours/day) and for the first 4-week period of monitoring (81.7 Ϯ 22.9 versus 59.5 Ϯ 31.3%, p ϭ 0.01) (19.6 Ϯ 5.5 versus 14.2 Ϯ 7.5 hours/day) was higher in infants who had an abnormality in the PCG at the time of discharge. Statistically significant differences were not detected in the analysis of gestational age and birth weight with respect to abnormal versus normal PCG results. During the second 4-week period, the compliance was similar between these two groups (Table 4) . Maternal age, education, or employment status did not affect compliance with apnea monitor use (Table 5) .
DISCUSSION
To our knowledge, this is the first prospective longitudinal study to describe the effect of an intervention targeted at compliance with home apnea monitoring. Results of this randomized, controlled study showed that weekly telephone contact with a health care professional did not significantly improve compliance with the monitor use. How- ever, these data show that families of infants at increased risk for sudden infant death syndrome generally use home apnea monitors. In addition, compliance was greater in subjects who had an abnormal PCG at the time of discharge from hospital. Maternal age, education, and employment had no effect on compliance.
Overall monitor use as well as the factors affecting compliance in this study are similar to those reported by Silvestri et al. 9 The results of their study were limited to the data from the first monitor download, which contained data from 7 to 29 days. Median monitor use in their population was 15.5 hours per day (64% of the time). Of the infants in their study, 75% were monitored for Ͼ10.5 hours, and 25% were monitored for Ͼ21 hours per day. Gibson et al. 10 followed 114 infants on documented monitoring. They selected 291 downloads, which were obtained at intervals between 10 to 86 days. A total of 72 downloads were not included in their analysis secondary to difficulty in obtaining the records at the appropriate time. They had an average monitor use of 15 Ϯ 5.12 hours per day (62 Ϯ 21%). Our study is the first to describe the pattern of use in the entire cohort of enrolled infants continuously monitored over a 2-month long period.
We defined compliance as the percentage of time the infant was on the monitor, as suggested by Silvestri et al. 9 We believe that this definition is practical and facilitates comparison between studies. During the first 4-week period, this definition accurately reflects the clinician's order to use the monitor at all times except during bathing. During the second 4-week period, this definition may not accurately reflect true compliance with the clinician's recommendation (of being monitored only during sleep and unattended times). Because of the difficulty in measuring compliance during all sleep and unattended times, we assumed that the time on the monitor represented sleeping and unattended time and that the actual number of hours spent in these activities is similar for all infants. This may in part explain the decrease in time on the monitor noted in the second 4-week period. Nevertheless, the families still used these monitors for almost 60% of the time in the second 4-week period.
Cordero et al. 8 reported the unreliability in the parental recall of compliance when compared with the computer printouts obtained from the downloads. Of the 26 parents who recalled never leaving the infants unmonitored, average daily use was only 18 of 24 hours (75%) for the theophylline-treated group and 16 of 24 hours (67%) for the unmedicated group. Our study demonstrates that documented monitoring is a practical and an objective alternative to parental recall.
Compliance is determined in part by the patients' beliefs regarding the level of threat posed by the health problem, including their perception of the severity of the problem. 11 This may explain the higher compliance noted in our patients who had abnormal PCG at the time of discharge.
In summary, weekly telephone contact did not affect parental compliance with home apnea monitoring. The only variable that was associated with improved compliance was an abnormal PCG result. Even though our reported compliance is higher than with other home therapies, the goal should approach 100% compliance. Some strategies to achieve this goal would be to use a documented monitor to evaluate a more extensive educational program or even to use the monitor as an intervention by providing the family with timely feedback and guidance regarding their actual compliance. 
